Radioimmunotherapy of human glioma xenografts in nude mice by indium-111 labelled internalising monoclonal antibody

European Journal of Cancer

Volumn 35, Issue 8, 1999, Pages 1281-1285

  Saga, T ^b   Sakahara, H ^b   Nakamoto, Y ^b   Sato, N ^b   Zhao, S ^b   Aoki, T ^b   Miyatake, S ^b   Namba, Y ^a   Konishi, J ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

Glioblastoma; Indium 111; Internalising antibody; Radioimmunotherapy

Indexed keywords

MONOCLONAL ANTIBODY I 125; MONOCLONAL ANTIBODY IN 111;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; GLIOBLASTOMA; GLIOMA; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; GLIOBLASTOMA; HUMANS; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032768197     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00120-3     Document Type: Article

References (23)

1. Sakahara H., Hosono M., Kobayashi H.et al. Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody. Jpn. J. Cancer Res. 87:1996;655-661.
2. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20:1993;283-292.
3. Sahu S.K., Kassis A.I., Makrigiorgos G.M., Baranowska-Kortylewicz J., Adelstein S.J. The effects of indium-111 decay on pBR322 DNA. Rad. Res. 141:1995;193-198.
4. Kondo S., Miyatake S., Iwasaki K.et al. Human glioma-specific antigens detected by monoclonal antibodies. Neurosurgery. 30:1992;506-511.
5. Matsuoka Y., Kuroki M., Koga Y., Kuriyama H., Mori T., Kosaki G. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces. Cancer Res. 42:1982;2012-2018.
6. Hunter W.N., Greenwood F.C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature. 194:1962;495-496.
7. Yao Z., Sakahara H., Zhang M.et al. Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody. Nucl. Med. Biol. 28:1995;861-870.
8. Lindmo T., Boven E., Cuttitta F., Fedorko J., Bunn Jr P.A. Determination of the immunoreactive fraction of radiolabeled monoclonal antibody by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods. 72:1984;77-89.
9. 125I radiolabeled T101 anti-CD5 monoclonal antibody. Nucl. Med. Biol. 17:1990;201-207.
10. Kaminski M.S., Zasadny K.R., Francis I.R.et al. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol. 14:1996;1974-1981.
11. Waldmann T.A., White J.D., Carrasquillo J.A.et al. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood. 86:1995;4063-4075.
12. Stepanek J., Larsson B., Weinreich R. Auger-electron spectra of radionuclides for therapy and diagnostics. Acta Oncol. 35:1996;863-883.
13. Hofer K.G. Biophysical aspects of Auger processes. Acta Oncol. 35:1996;789-796.
14. Kassis A.I., Adelstein S.J. Preclinical animal studies with radioiododeoxyuridine. J. Nucl. Med. 37(Suppl.):1996;10s-12s.
15. O'Donoghue J.A. Strategies for selective targeting of auger electron emitters to tumor cells. J. Nucl. Med. 37(Suppl.):1996;3s-6s.
16. Welt S., Scott A.M., Divgi C.R.et al. Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. J. Clin. Oncol. 14:1996;1787-1797.
17. 131I-labeled CO17-1A in human colorectal cancer model. Int. J. Cancer. 76:1998;738-748.
18. Kairemo K.J.A., Ramsay H.A., Tagesson M.et al. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancerdosimetric and biokinetic aspects. Eur. J. Nucl. Med. 23:1996;631-638.
19. 1]-octreotide. Ann. NY Acad. Sci. 733:1994;496-506.
20. Krenning E.P., Kooij P.P.M., Pauwels S.et al. Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion. 57(Suppl. 1):1996;57-61.
21. Saga T., Sakahara H., Yao Z.et al. Detection of altered adhesion molecule expression in experimental tumors by a radiolabeled monoclonal antibody. Jap. J. Cancer Res. 88:1997;1171-1180.
22. Press O.W., Shan D., Howell-Clerk J.et al. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res. 56:1996;2123-2129.
23. Faraggi M., Gardin I., de Labriolle-Vaylet C., Moretti J.L., Bok B.D. The influence of tracer localization on the electron dose rate delivered to the cell nucleus. J. Nucl. Med. 35:1994;113-119.